r.marsden

TL3 Regular · Granada, ES

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 11 November 2024 · last posted 1d · groups: analytical-chemists

159 posts, newest first. Showing up to 150.

MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #7 · marked as the solution · Analytics › Mass spectrometry · 27 Jul 2026 · 7 likes Everything in post #3 holds. The case it does not cover is the one I have. Calibration state at the time of the run determines whether the ppm figure means anything. A…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #89 · Practice › Dosing & titration · 23 Jul 2026 · 10 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #115 · Devices › Syringes & needles · 22 Jul 2026 · 19 likes I read post #111 twice before replying, because I had assumed the opposite. Reading the barrel at eye level matters more than any equipment choice. Parallax at a…
Which categories are strict and which are relaxed, honestly Replied, post #37 · Start Here › Welcome · 22 Jul 2026 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #118 · Outcomes › Body composition · 20 Jul 2026 · 1 like Where I part company with post #116, and it is a narrow parting. Neither method is capable of detecting the month-to-month changes that people report detecting month to…
What I would want from a home test that does not exist yet — what changed since Replied, post #101 · Analytics › Home & field testing · 19 Jul 2026 · 21 likes Worth separating two things that post #99 runs together. Nothing available at home distinguishes a correct sequence from a closely related incorrect one. That gap is…
Request: tag synonyms surfaced in search Replied, post #20 · Meta › Feature requests · 17 Jul 2026 · 0 likes Request that would help newcomers more than regulars: show the subcategory description on hover in the category list. The names are terse and the descriptions are good.
Seven-day rolling means and why weekly readings mislead Replied, post #46 · Outcomes › Progress reports · 17 Jul 2026 · 0 likes Filing a mild objection to the consensus on seven-day rolling. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #20 · Sourcing › Payments · 14 Jul 2026 · 1 like Post #18 and I disagree about the size of the effect, not about the direction. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit…
A site rotation scheme that is easy enough to actually follow Replied, post #105 · Practice › Administration · 4 Jul 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #35 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 0 likes Post #33 and I disagree about the size of the effect, not about the direction. The version of GHRH analogues versus ghrelin mimetics that circulates here is a…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #88 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 0 likes Adding a small correction to the Carryover summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
Primary endpoint hierarchies and why order matters — one year on Replied, post #27 · Evidence › Trials · 27 Jun 2026 · 0 likes Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #47 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 16 likes The failure mode on secretagogues and glucose tolerance is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #63 · Analytics › HPLC & UHPLC · 23 Jun 2026 · 13 likes The honest answer on Carryover is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #16 · Analytics › Impurities & related substances · 22 Jun 2026 · 9 likes Nothing to add, except that this is the answer I would give if asked.
When a dose reduction is the correct response to a side effect Replied, post #31 · Practice › Dosing & titration · 20 Jun 2026 · 0 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #115 · Practice › Reconstitution · 18 Jun 2026 · 28 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #66 · Meta › Announcements · 17 Jun 2026 · 4 likes Where I part company with post #62, and it is a narrow parting. Thank you for announcing it in advance rather than after. The number of places that do the reverse is…
Official shortage notices and what they authorise Replied, post #107 · Access › Shortages · 15 Jun 2026 · 0 likes I had written a reply contradicting post #105 and deleted it. Here is what survived. Shortage status determines what compounding is permitted in some jurisdictions,…
Injection volume, overload, and peak distortion Replied, post #48 · Analytics › HPLC & UHPLC · 12 Jun 2026 · 0 likes Where I part company with post #46, and it is a narrow parting. I would put moderate confidence on the mainstream reading of injection volume and no more. That is not…
What to include when your question involves a chromatogram — one year on Replied, post #34 · Start Here › How to Ask · 12 Jun 2026 · 25 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #78 · Data & Tools › Datasets · 10 Jun 2026 · 24 likes Post #75 is the version of this I will quote in future. One addition. Date every record. A dataset assembled over two years without dates cannot distinguish a change…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #11 · Pharmacology › Receptor biology · 5 Jun 2026 · 0 likes Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic thread starts being used to justify a sourcing decision. I have…
Batch numbers that do not match the vial label — what changed since Replied, post #29 · Sourcing › Red flags · 4 Jun 2026 · 13 likes Post #27 is the version of this I will quote in future. One addition. A note on how Batch numbers gets discussed rather than on Batch numbers itself: the confident…
Does dual agonism explain the effect size, or is it dose? Replied, post #11 · Compounds › Tirzepatide · 1 Jun 2026 · 26 likes The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic behaves the way you would naively expect. That is not…
The best-written scientific paper you have read Replied, post #75 · Lounge › Off topic · 31 May 2026 · 0 likes Adding a reference point for best-written scientific paper. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
[2026 update] Thyroid function tests during substantial weight change Replied, post #75 · Clinical › Bloodwork · 22 May 2026 · 15 likes Narrowing post #72, because the general version has more than one answer. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #8 · Evidence › Meta-analyses · 21 May 2026 · 10 likes Same experience here, different supplier, so it is at least not unique to one of them.
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #26 · Practice › Administration · 11 May 2026 · 0 likes Avoid any area that is currently reacting, and avoid any area that has become firm or lumpy. That is not caution about comfort; tissue that has changed does not absorb…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #27 · Compounds › Tirzepatide · 6 May 2026 · 0 likes Tirzepatide and nausea: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Anaesthesia and elective surgery: the aspiration question Replied, post #112 · Practice › Interactions · 5 May 2026 · 0 likes Answering the question post #110 raises rather than the one it answers. Anaesthesia and elective surgery looks different depending on whether you are reading the…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #12 · Compounds › Tirzepatide · 1 May 2026 · 5 likes I read the earlier replies on Tirzepatide and nausea twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
Journal club: is percentage weight change the right endpoint? Replied, post #121 · Evidence › Journal club · 30 Apr 2026 · 27 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
Request: show the solution author in the topic list — what changed since Replied, post #9 · Meta › Feature requests · 30 Apr 2026 · 29 likes I would use that constantly. The objection is presumably that it is data the site then has to hold and protect for no benefit to anyone else.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #7 · Compounds › Tirzepatide · 28 Apr 2026 · 0 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
Coming back to: Measurement error in a self-reported exposure Replied, post #21 · Evidence › Study critique · 26 Apr 2026 · 0 likes Speaking only to Measurement error as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
Documenting a payment dispute without naming and shaming Replied, post #7 · Sourcing › Payments · 21 Apr 2026 · 13 likes Where I part company with post #3, and it is a narrow parting. No payment facilitation: this site does not handle payments and does not connect buyers and sellers for…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #14 · Compounds › Repair & healing peptides · 20 Apr 2026 · 6 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. BPC-157: the preclinical literature is extensive, mostly from a small number of…
Transporting a vial for a weekend away — a second dataset Replied, post #31 · Practice › Storage & stability · 18 Apr 2026 · 6 likes What I would want before treating Transporting a vial as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
Revisiting: Drawing up with one needle and injecting with another Replied, post #50 · Practice › Administration · 5 Apr 2026 · 0 likes This follows post #47 rather than contradicting it. Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs…
Preprint servers and what screening they do Replied, post #94 · Evidence › Preprints · 19 Mar 2026 · 11 likes Post #91 and I disagree about the size of the effect, not about the direction. Reading a preprint properly means doing some of the reviewer's job: methods first, then…
Which fields on a certificate actually matter, ranked Replied, post #16 · Analytics › COA interpretation · 15 Mar 2026 · 0 likes This follows post #13 rather than contradicting it. An itemised related-substances table with retention times says considerably more about the synthesis than a single…
Oral versus injected administration claims for BPC-157 Replied, post #9 · Compounds › Repair & healing peptides · 11 Mar 2026 · 1 like Right — I had this wrong and I am glad to have read it before it mattered.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #18 · Lounge › Introductions · 9 Mar 2026 · 0 likes Introductions are also a reasonable place to say what you are hoping to find, because somebody will usually know whether it exists here already.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #6 · Compounds › Repair & healing peptides · 7 Mar 2026 · 8 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Research-use-only status: what it means legally and practically Replied, post #11 · Compounds › Other compounds · 6 Mar 2026 · 4 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Waist circumference technique and its repeatability Replied, post #57 · Outcomes › Progress reports · 28 Feb 2026 · 11 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 27 Feb 2026 · 12 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. I would rather this thread reach "we do not know" about Amylin and gastric emptying…
Guidelines revision: what changed and why — one year on Replied, post #74 · Meta › Announcements · 23 Feb 2026 · 10 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. Take it as a starting point and not as a specification.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #129 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
The most useful thing you learned here that was not the answer you came for Replied, post #21 · Lounge › Off topic · 16 Feb 2026 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #46 · Outcomes › Progress reports · 13 Feb 2026 · 18 likes Everything in post #44 holds. The case it does not cover is the one I have. I would be cautious about generalising from the Seven-day rolling example above. It is a…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #25 · Practice › Administration · 11 Feb 2026 · 10 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #2 · Practice › Administration · 31 Jan 2026 · 0 likes My understanding of completing a dose is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Reused chromatograms across lots: how to spot it — what changed since Replied, post #14 · Analytics › COA interpretation · 29 Jan 2026 · 11 likes A note on scope: what I am saying about Reused chromatograms across lots applies to the case in the first post and I would not extend it further without checking.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #68 · Access › Pricing · 22 Jan 2026 · 21 likes A methods point on Price changes rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Distinguishing expected GI effects from something that needs urgent attention Replied, post #102 · Practice › Side effects · 14 Jan 2026 · 12 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
Amylin receptor signalling and satiety — what changed since Replied, post #16 · Pharmacology › Receptor biology · 14 Jan 2026 · 2 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #75 · Clinical › Special populations · 14 Jan 2026 · 2 likes Post #74 is right about the mechanism and I think understates the practical bit. Genetic and ancestry-related differences in response are asked about regularly and the…
Pharmacy supply in the UK and the questions you will be asked Replied, post #3 · Regional › UK & Ireland · 4 Jan 2026 · 14 likes Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory jurisdictions and the answer is frequently different.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #51 · Access › Pricing · 1 Jan 2026 · 18 likes Where somebody posts a comparison, the useful version states the date, the region and what was included. The answer changed when I changed how I was measuring, which…
Vomiting: when it is expected and when it is a reason to stop Replied, post #84 · Practice › Side effects · 29 Dec 2025 · 14 likes Where I part company with post #82, and it is a narrow parting. The practical division worth making is between symptoms that are unpleasant, symptoms that are limiting,…
Preprint servers and what screening they do Replied, post #7 · Evidence › Preprints · 24 Dec 2025 · 6 likes Worth separating two things that post #3 runs together. Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the…
How to ask about something you suspect is a bad idea Replied, post #37 · Start Here › How to Ask · 24 Dec 2025 · 5 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #76 · Compounds › Semaglutide · 24 Dec 2025 · 7 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
Angle of injection and whether 90 degrees is always right Replied, post #69 · Practice › Administration · 21 Dec 2025 · 0 likes Confirming post #68 from a second method, which matters more than confirming it from a second person. Subcutaneous injection into abdominal tissue, thigh or upper arm…
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #21 · Safety › Contraindications · 9 Dec 2025 · 10 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #40 · Start Here › How to Ask · 9 Dec 2025 · 8 likes I read post #36 twice before replying, because I had assumed the opposite. Five questions in one post gets you one answer: the easiest one, usually not the one you…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #31 · Data & Tools › Calculators · 7 Dec 2025 · 5 likes Source for the Feature request figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #8 · Sourcing › Red flags · 6 Dec 2025 · 9 likes Narrowing post #6, because the general version has more than one answer. Claims of pharmaceutical-grade status for research-use-only material are a labelling problem…
Tracking a preprint to publication: a worked example Replied, post #54 · Evidence › Preprints · 5 Dec 2025 · 1 like Where the tracking a preprint discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #12 · Compounds › Tirzepatide · 1 Dec 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #79 · Compounds › Other compounds · 25 Nov 2025 · 0 likes Post #77 and I disagree about the size of the effect, not about the direction. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #89 · Compounds › Tirzepatide · 17 Nov 2025 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Thyroid function tests during substantial weight change Replied, post #135 · Clinical › Bloodwork · 15 Nov 2025 · 9 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial. That is the…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #17 · Research Methods › N-of-1 designs · 6 Nov 2025 · 17 likes Narrowing post #16, because the general version has more than one answer. Stopping rules: decide in advance when you will stop measuring (after a defined duration,…
Meeting a protein target on a suppressed appetite Replied, post #33 · Nutrition & Training › Protein & intake · 6 Nov 2025 · 0 likes The reports here that describe what actually worked, in specifics, are far more useful than the ones stating a target. I have separated what I observed from what I…
Oral semaglutide bioavailability and its variability between people Replied, post #13 · Compounds › Oral incretins · 5 Nov 2025 · 5 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
What pooling buys you and what it destroys Replied, post #54 · Evidence › Meta-analyses · 30 Oct 2025 · 23 likes Small methodological point on pooling buys: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #49 · Pharmacology › Receptor biology · 7 Oct 2025 · 16 likes I had written a reply contradicting post #45 and deleted it. Here is what survived. Endogenous versus pharmacological receptor engagement differ in magnitude and in…
NHS criteria and how they are applied in practice — the long version Replied, post #9 · Regional › UK & Ireland · 6 Oct 2025 · 23 likes This follows post #8 rather than contradicting it. An update on my earlier NHS criteria post: the pattern held for another six weeks and then stopped, which I did not…
Thyroid function tests during substantial weight change Replied, post #83 · Clinical › Bloodwork · 3 Oct 2025 · 0 likes Thyroid function tests during substantial: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #15 · Analytics › HPLC & UHPLC · 29 Sep 2025 · 10 likes Integrator sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Insurance and replacement policies, compared — the long version Replied, post #17 · Sourcing › Logistics · 19 Sep 2025 · 27 likes Post #16 answers the question as asked. The question underneath it is different. Insurance and replacement policies: I have looked for the primary source twice and…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #52 · Analytics › Method validation · 15 Sep 2025 · 21 likes Precision has two levels worth distinguishing: repeatability within a run and intermediate precision across days, analysts and instruments. The second is where most…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #86 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes A dataset is only useful if the collection method is described alongside it. Numbers without a protocol are a list rather than data.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #127 · Wellbeing › Mental health · 6 Sep 2025 · 0 likes Distinguishing three things in the history of disordered eating discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Reading an interaction checker output critically Started this topic · Practice › Interactions · 2 Sep 2025 · 8 likes On the subject in the title: Reading an interaction checker output critically Working notes rather than a conclusion. A question about reading an interaction checker…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #7 · Compounds › Tirzepatide · 27 Aug 2025 · 25 likes Post #6 is right about the mechanism and I think understates the practical bit. The version of dual agonism that I was taught turned out to be a teaching…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #21 · Analytics › Method validation · 25 Aug 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Why catalogue breadth is not evidence of anything — what changed since Replied, post #23 · Compounds › Other compounds · 19 Aug 2025 · 10 likes Adding thanks rather than a view. I do not have a view worth the space.
Temperature loggers worth the money Replied, post #20 · Devices › Cold chain · 18 Aug 2025 · 19 likes Reading this temperature loggers worth the money thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #40 · Evidence › Journal club · 15 Aug 2025 · 11 likes Taking post #39 at face value and following it one step further. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #79 · Sourcing › Regulatory · 14 Aug 2025 · 0 likes Marking my uncertainty on compound being unapproved explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
MALDI versus ESI for a quick identity check Started this topic · Analytics › Mass spectrometry · 5 Aug 2025 · 2 likes On the subject in the title: MALDI versus ESI for a quick identity check Working notes rather than a conclusion. I was wrong about MALDI versus ESI in a thread last…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #79 · Compounds › Repair & healing peptides · 24 Jul 2025 · 0 likes The confident answers on TB-500 and thymosin beta-4 and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #45 · Meta › Wiki maintenance · 21 Jul 2025 · 3 likes Worth separating two things that post #43 runs together. That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
Repeatability versus intermediate precision Replied, post #109 · Analytics › Method validation · 1 Jul 2025 · 28 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #34 · Data & Tools › Calculators · 25 Jun 2025 · 0 likes Post #32 put the caveat in the right place and I want to underline it. A titration planner is a scheduling aid rather than a clinical recommendation, and any tool that…
Repeatability versus intermediate precision Replied, post #12 · Analytics › Method validation · 18 Jun 2025 · 6 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
A claim built entirely on a subgroup analysis Replied, post #44 · Evidence › Study critique · 20 May 2025 · 0 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
Pregnancy as an absolute contraindication Replied, post #49 · Safety › Contraindications · 18 May 2025 · 0 likes Answering the question post #46 raises rather than the one it answers. Nothing here is medical advice, and a contraindication question is one where the cost of a wrong…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #152 · Sourcing › Regulatory · 14 May 2025 · 0 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. Adding the caveat now so…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #84 · Sourcing › Independent verification · 12 May 2025 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
Follow-up: Documentation that appears only after payment Replied, post #63 · Sourcing › Red flags · 10 May 2025 · 0 likes This follows post #62 rather than contradicting it. I would call the community position on Documentation likely rather than established, and I would be comfortable…
Shakes versus food: a pragmatic assessment — the long version Replied, post #15 · Nutrition & Training › Protein & intake · 3 May 2025 · 4 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. The uncertainty…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #53 · Compounds › Secretagogues & GH axis · 1 May 2025 · 11 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
UK access routes, dated and sourced — a second dataset Replied, post #70 · Regional › UK & Ireland · 28 Apr 2025 · 0 likes Everything in post #68 holds. The case it does not cover is the one I have. Members outside these two jurisdictions reading this thread should note that none of it…
Dizziness on standing: the ordinary explanation first Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 27 Apr 2025 · 0 likes This follows post #17 rather than contradicting it. Where a laboratory result exists, quoting it with the reference interval makes the discussion tractable. Without it…
Ipamorelin selectivity claims and where they came from Replied, post #32 · Compounds › Secretagogues & GH axis · 26 Apr 2025 · 3 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #13 · Evidence › Journal club · 26 Apr 2025 · 7 likes Narrowing post #10, because the general version has more than one answer. The figures usually contain the finding and the text usually contains the interpretation.…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #59 · Practice › Interactions · 24 Apr 2025 · 23 likes What would change my mind on delayed gastric emptying and oral is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #5 · Sourcing › Independent verification · 22 Apr 2025 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Small methodological point on Janoshik: repeating a measurement is cheap and…
Validating a calculator against hand arithmetic — what changed since Replied, post #27 · Data & Tools › Calculators · 21 Apr 2025 · 1 like Post #25 is the version of this I will quote in future. One addition. Checking a tool against a worked example you already trust is five minutes well spent, and it is…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #79 · Compounds › Semaglutide · 16 Apr 2025 · 10 likes The arithmetic on SELECT is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Reflectance and photometric devices: precision in practice Started this topic · Analytics › Home & field testing · 14 Apr 2025 · 48 likes On the subject in the title: Reflectance and photometric devices: precision in practice Working notes rather than a conclusion. I was wrong about reflectance and…
Requesting a page: what makes a good request Replied, post #50 · Documentation › Wiki requests · 8 Apr 2025 · 9 likes Say what would make the page wrong. A page whose failure conditions are stated is much easier to review honestly. Worth saying I have only my own numbers here, and n is…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #54 · Practice › Reconstitution · 7 Apr 2025 · 0 likes Worth separating two things that post #51 runs together. Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution,…
Retatrutide dose escalation in the published trials Replied, post #34 · Compounds › Retatrutide · 21 Mar 2025 · 2 likes Confirming post #31 from a second method, which matters more than confirming it from a second person. I would be cautious about generalising from the retatrutide dose…
When "no data" is the complete and final answer Replied, post #122 · Compounds › Other compounds · 18 Mar 2025 · 0 likes Taking post #120 at face value and following it one step further. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
Charge states for a 4 kDa peptide, worked through Replied, post #139 · Analytics › Mass spectrometry · 18 Mar 2025 · 10 likes The arithmetic in post #136 is right; the assumption feeding it is the part to check. The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the…
Maintainer handover: how it works Replied, post #29 · Meta › Wiki maintenance · 15 Mar 2025 · 31 likes On maintainer handover I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #105 · Sourcing › Regulatory · 14 Mar 2025 · 9 likes The most useful reply I ever got about Research-use-only labelling was a request to state my units. It sounds like pedantry and it has saved me twice.
Biased agonism: a real phenomenon, an over-used explanation Replied, post #79 · Pharmacology › Receptor biology · 11 Mar 2025 · 0 likes Everything in post #75 holds. The case it does not cover is the one I have. Biased agonism — where different ligands at the same receptor favour different downstream…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #12 · Access › Pricing · 8 Mar 2025 · 4 likes I changed my mind about Manufacturer assistance programmes after someone here asked me for the source and I could not produce one. That is worth saying out loud because…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #11 · Sourcing › Regulatory · 27 Feb 2025 · 28 likes I would put moderate confidence on the mainstream reading of pharmaceutical compounding rules and no more. That is not scepticism for its own sake; it is where the…
Distinguishing a deletion sequence by mass alone Replied, post #121 · Analytics › Mass spectrometry · 22 Feb 2025 · 20 likes Building on post #118 rather than restating it. For a compound with no reference standard in circulation, an observed mass is much more useful than an assertion of…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #51 · Pharmacology › Receptor biology · 14 Feb 2025 · 21 likes The useful distinction on Biased agonism is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Protein density versus volume when you cannot eat much Replied, post #60 · Nutrition & Training › Protein & intake · 3 Feb 2025 · 3 likes I have three months of notes on protein density versus volume and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
Second pass at: Multiplicity when you track fifteen variables Replied, post #3 · Research Methods › Statistics · 2 Feb 2025 · 6 likes Taking the opening post at face value and following it one step further. Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a…
When to suspect the method rather than the sample Replied, post #74 · Analytics › Method validation · 30 Jan 2025 · 10 likes Post #71 is right about the mechanism and I think understates the practical bit. Documented validation is what separates a number from an opinion expressed numerically.…
SURPASS-2 and the comparator dose question that will not go away Replied, post #107 · Compounds › Tirzepatide · 17 Jan 2025 · 0 likes On SURPASS-2 the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Recovery when intake is low: what to cut first Replied, post #16 · Nutrition & Training › Resistance training · 10 Jan 2025 · 11 likes Everything in post #12 holds. The case it does not cover is the one I have. Recovery sits at the boundary between what this community can usefully discuss and what it…
A promotion I argued against, and why I lost Replied, post #46 · Documentation › Doc review · 31 Dec 2024 · 2 likes The failure mode on promotion is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #41 · Practice › Interactions · 25 Dec 2024 · 3 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
The topic list is dense — is that deliberate? Replied, post #72 · Meta › Site feedback · 25 Dec 2024 · 29 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #37 · Compounds › Semaglutide · 24 Dec 2024 · 21 likes This is the first time the answer has come with its own limits attached. Appreciated.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #68 · Access › Insurance & coverage · 13 Dec 2024 · 6 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
Identical chromatograms across two different lots Replied, post #61 · Sourcing › Red flags · 12 Dec 2024 · 31 likes Agreed, and I will stop repeating the version of this I had been repeating.
Washout with a one-week half-life: the arithmetic Replied, post #81 · Research Methods › N-of-1 designs · 7 Dec 2024 · 0 likes An n of one tells you about one person, which is the person you are most interested in. That is the whole value and it is not nothing. Happy to be the one who is wrong…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #45 · Evidence › Journal club · 28 Nov 2024 · 5 likes If you are new and reading this thread for the answer to SURPASS-2: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
Coming back to: When to suspect the method rather than the sample Replied, post #5 · Analytics › Method validation · 28 Nov 2024 · 1 like The opening post and I disagree about the size of the effect, not about the direction. A stability-indicating method is one demonstrated to resolve the analyte from its…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #11 · Compounds › Tirzepatide · 27 Nov 2024 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #38 · Compounds › Semaglutide · 22 Nov 2024 · 12 likes Nausea is dose-related and adaptation-related, and both are true at once. The pattern most people describe is a return of symptoms at each escalation followed by…
EMA product information as a primary source — does this still hold? Replied, post #56 · Regional › European Union · 16 Nov 2024 · 5 likes Small methodological point on EMA product information: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Follow-up: Trifluoroacetate content and its consequences Replied, post #16 · Analytics › Impurities & related substances · 21 Oct 2024 · 16 likes On Trifluoroacetate content, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Promotion criteria, and the one that stops most nominations Replied, post #91 · Documentation › Doc review · 20 Oct 2024 · 1 like The arithmetic in post #88 is right; the assumption feeding it is the part to check. Reviewing your own nomination is fine and is not sufficient. Somebody else has to…
Hypertension improvement and when medication needs revisiting — a second dataset Started this topic · Clinical › Comorbidities · 6 Oct 2024 · 11 likes Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that.…
When a red flag was a misunderstanding, and the retraction Replied, post #21 · Sourcing › Red flags · 22 Sep 2024 · 28 likes Narrowing post #18, because the general version has more than one answer. Where somebody posts a concern, ask what would resolve it before arguing about it. Half of…